Inhibition of normal lymphocyte proliferation by Indirubin-3′-monoxime: A multifactorial process

References

• Hoessel R, Leclerc S, Endicott J A, Nobel M E, Lawrie A, Tunnah P, et al. Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol 1999; 1: 60–67
   PubMed Web of Science ®Google Scholar
• Xiao Z, Hao Y, Liu B, Qian L. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China. Leuk Lymphoma 2002; 43: 1763–1768
   PubMed Web of Science ®Google Scholar
• Marko D, Schatzle S, Friedel A, Genzlinger A, Zankl H, Meijer L, et al. Inhibition of cyclin-dependent kinase 1 (CDK1) by indirubin derivatives in human tumour cells. Br J Cancer 2001; 84: 283–289
   PubMed Web of Science ®Google Scholar
• Toledo L M, Lydon N B, Elbaum D. The structure-based design of ATP-site directed protein kinase inhibitors. Curr Med Chem 1999; 6: 775–805
   PubMed Web of Science ®Google Scholar
• Senderowicz A M. Development of cyclin-dependent kinase modulators as novel therapeutic approaches for hematological malignancies. Leukemia 2001; 15: 1–9
   PubMed Web of Science ®Google Scholar
• Knockaert M, Greengard P, Meijer L. Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol Sci 2002; 23: 417–425
   PubMed Web of Science ®Google Scholar
• Knockaert M, Gray N, Damiens E, Chang Y T, Grellier P, Grant K, et al. Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem Biol 2000; 7: 411–422
   PubMed Web of Science ®Google Scholar
• Damiens E, Baratte B, Marie D, Eisenbrand G, Meijer L. Anti-mitotic properties of indirubin-3′-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest. Oncogene 2001; 20: 3786–3797
   PubMed Web of Science ®Google Scholar
• Leclerc S, Garnier M, Hoessel R, Marko D, Bibb J A, Snyder G L, et al. Indirubins inhibit glycogen synthase kinase-3β and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?. J Biol Chem 2001; 276: 251–260
   PubMed Web of Science ®Google Scholar
• Diehl J A, Cheng M, Roussel M F, Sherr C J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12: 3499–3511
   PubMed Web of Science ®Google Scholar
• Ohteki T, Parsons M, Zakarian A, Jones R G, Nguyen L T, Woodgett J R, et al. Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3. J Exp Med 2000; 192: 99–104
   PubMed Web of Science ®Google Scholar
• Adachi J, Mori Y, Matsui S, Takigami H, Fujino J, Kitagawa H, et al. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J Biol Chem 2001; 276: 31475–31478
   PubMed Web of Science ®Google Scholar
• Elferink C J. Aryl hydrocarbon receptor-mediated cell cycle control. Prog Cell Cycle Res 2003; 5: 261–267
   PubMedGoogle Scholar
• Nam S, Buettner R, Turkson J, Kim D, Cheng J Q, Muehlbeyer S, et al. Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells. Proc Natl Acad Sci USA 2005; 102: 5998–6003
   PubMed Web of Science ®Google Scholar
• Ng J, Cantrell D. STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J Biol Chem 1997; 272: 24542–24549
   PubMedGoogle Scholar
• Modiano J F, Domenico J, Szepesi A, Lucas J J, Gelfand E W. Differential requirements for interleukin-2 distinguish the expression and activity of the cyclin-dependent kinases Cdk4 and Cdk2 in human T cells. J Biol Chem 1994; 269: 32972–32978
   PubMed Web of Science ®Google Scholar
• Ajchenbaum F, Ando K, DeCaprio J A, Griffin J D. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J Biol Chem 1993; 268: 4113–4119
   PubMed Web of Science ®Google Scholar
• Firpo E J, Koff A, Solomon M J, Roberts J M. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 1994; 14: 4889–4901
   PubMed Web of Science ®Google Scholar
• Nourse J, Firpo E, Flanagan W M, Coats S, Polyak K, Lee M H. Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 1994; 372: 570–573
   PubMed Web of Science ®Google Scholar
• Peiretti A, Baghdassarian N, Gerland L M, Ffrench P, Bryon P A, Magaud J P, et al. CDK2 is involved in the S-phase lengthening induced by glucocorticoids in normal human lymphocytes. Eur J Cell Biol 2003; 82: 253–261
   Google Scholar
• Vella A T, Dow S, Potter T A, Kappler J, Marrack P. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95: 3810–3815
   PubMed Web of Science ®Google Scholar
• Akbar A N, Borthwick N J, Wickremasinghe R G, Panayoitidis P, Pilling D, Bofill M, et al. Interleukin-2 receptor common γ-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol 1996; 26: 294–299
   PubMed Web of Science ®Google Scholar
• Brunn G J, Falls E L, Nilson A E, Abraham R T. Protein-tyrosine kinase-dependent activation of STAT transcription factors in interleukin-2- or interleukin-4-stimulated T lymphocytes. J Biol Chem 1995; 270: 11628–11635
   PubMed Web of Science ®Google Scholar
• Stephanou A, Brar B K, Knight R A, Latchman D S. Opposing actions of STAT-1 and STAT-3 on the Bcl-2 and Bcl-x promoters. Cell Death Differ 2000; 7: 329–330
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Ray R M, Johnson L R. STAT3-mediated transcription of Bcl-2, Mcl-1 and c-IAP2 prevents apoptosis in polyamine-depleted cells. Biochem J 2005; 392: 335–344
   PubMed Web of Science ®Google Scholar
• Battle T E, Frank D A. The role of STATs in apoptosis. Curr Mol Med 2002; 2: 381–392
   PubMedGoogle Scholar
• Baghdassarian N, Catallo R, Mahly M A, Ffrench P, Chizat F, Bryon P A, et al. Glucocorticoids induce G1 as well as S-phase lengthening in normal human stimulated lymphocytes: differential effects on cell cycle regulatory proteins. Exp Cell Res 1998; 240: 263–273
   PubMed Web of Science ®Google Scholar
• Quemeneur L, Flacher M, Gerland L M, Ffrench M, Revillard J P, Bonnefoy-Berard N. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis. J Immunol 2002; 169: 2747–2755
   PubMed Web of Science ®Google Scholar
• Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz M A, Lassota P, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992; 13: 795–808
   PubMedGoogle Scholar
• Wong H, Anderson W D, Cheng T, Riabowol K T. Monitoring mRNA expression by polymerase chain reaction: the “primer-dropping” method. Anal Biochem 1994; 223: 251–258
   PubMed Web of Science ®Google Scholar
• Mekki Y, Catallo R, Bertrand Y, Manel A M, Ffrench P, Baghdassarian N, et al. Enhanced expression of p16ink4a is associated with a poor prognosis in childhood acute lymphoblastic leukemia. Leukemia 1999; 13: 181–189
   PubMed Web of Science ®Google Scholar
• Kroemer G, El-Deiry W S, Golstein P, Peter M E, Vaux D, Vandenabeele P, et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005; 12(Suppl. S2)1463–1467
   PubMed Web of Science ®Google Scholar
• Zarkowska T, Mittnacht S. Differential phosphorylation of retinoblastoma protein by G1/S cyclin dependent kinases. J Biol Chem 1997; 272: 12738–12746
   PubMed Web of Science ®Google Scholar
• Knudsen E S, Wang J Y. Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites. J Biol Chem 1996; 271: 8313–8320
   PubMed Web of Science ®Google Scholar
• Eisenbrand G, Hippe F, Jakobs S, Muehlbeyer S. Molecular mechanisms of indirubin and its derivatives: novel anticancer molecules with their origin in traditional Chinese phytomedicine. J Cancer Res Clin Oncol 2004; 130: 627–635
   PubMed Web of Science ®Google Scholar
• Wolowiec D, Benchaib M, Pernas P, Deviller P, Souchier C, Rimokh R, et al. Expression of cell cycle regulatory proteins in chronic lymphocytic leukemias. Comparison with non-Hodgkin's lymphomas and non-neoplastic lymphoid tissue. Leukemia 1995; 9: 1382–1388
   PubMed Web of Science ®Google Scholar
• Wolowiec D, Deviller P, Simonin D, Souchier C, Rimokh R, Bryon P A, et al. CDK1 is a marker of cell proliferation in human lymphoid cells. Int J Cancer 1995; 61: 381–388
   PubMed Web of Science ®Google Scholar
• Serizawa H, Makela T P, Conaway J W, Conaway R C, Weinberg R A, Young R A. Association of Cdk-activating kinase subunits with transcription factor TFIIH. Nature 1995; 374: 280–282
   PubMed Web of Science ®Google Scholar
• Poon R Y, Yamashita K, Adamczewski J P, Hunt T, Shuttleworth J. The cdc2-related protein p40MO15 is the catalytic subunit of a protein kinase that can activate p33cdk2 and p34cdc2. EMBO J 1993; 12: 3123–3132
   PubMed Web of Science ®Google Scholar
• Xie Y, Liu Y, Ma C, Yuan Z, Wang W, Zhu Z, et al. Indirubin-3′-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons. Neurosci Lett 2004; 367: 355–359
   PubMed Web of Science ®Google Scholar
• Mak N K, Leung C Y, Wei X Y, Shen X L, Wong R NS, Leung K N, et al. Inhibition of RANTES expression by indirubin in influenza virus-infected human bronchial epithelial cells. Biochem Pharmacol 2004; 67: 167–174
   PubMed Web of Science ®Google Scholar
• Knockaert M, Blondel M, Bach S, Leost M, Elbi C, Hager G L, et al. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 2004; 23: 4400–4412
   PubMed Web of Science ®Google Scholar
• Meijer L, Skaltsounis A L, Magiatis P, Polychronopoulos P, Knockaert M, Leost M, et al. GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol 2003; 10: 1255–1266
   PubMed Web of Science ®Google Scholar